revolutionize drug development
Predicting Clinical Trial Readiness of Drug Candidates using AI
About Us
Our mission
BiolomiX is an innovative startup company poised to revolutionize the pharmaceutical industry with its groundbreaking approach to predicting clinical trial readiness of drug candidates. Focused on assessing both, the toxicity and efficacy of drugs, BiolomiX aims to streamline the drug development process and improve patient outcomes.
Our platform
At the heart of BiolomiX's mission is a cutting-edge platform that harnesses advanced network analysis and AI techniques. By leveraging preclinical omics data, including transcriptomics, proteomics, and metabolomics, we are able to uncover intricate patterns and relationships within small and big datasets.
AI at its best
The platform's capabilities enable BiolomiX to identify key molecular interactions of biological pathways that influence a drug's safety and effectiveness. This comprehensive understanding provides valuable insights into potential adverse effects and therapeutic benefits, enhancing decision-making throughout the drug development lifecycle.